MenoGeniX's Grant

MenoGeniX raised a round of funding on May 03, 2018. Investors include National Institute on Aging.

MenoGeniX is a clinical stage biotechnology company focused on the development of an approved drug, in a new indication, menopause, and the menopause-like symptoms that occur in certain breast and pro…

Articles about MenoGeniX's Grant: